Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil for Double-J Stent Discomfort
NCT01959074Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naftopidil in ureteral stent syndrome (SRS), sponsored by Seoul National University Hospital. Started May 2014; status: completed.
02
Drugs
naftopidil
03
Conditions
ureteral stent syndrome (SRS)
Beyond the preview
Go deeper on NCT01959074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959074.